Journal ArticleOPEN ACCESS

First report of an extensively drug-resistant VIM-2 metallo-β- lactamase-producing Brevundimonas diminuta clinical isolate

Journal of Clinical Microbiology (2012) 50(8) 2830-2832
DOI: 10.1128/JCM.00924-12
20Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the literature, only three Brevundimonas diminuta environmental isolates carrying metallo-β-lactamase genes were recently published. However, so far, no B. diminuta clinical isolates carrying these carbapenem resistance genes have been described. Here we report the first VIM-2 metallo-β-lactamase- producing B. diminuta clinical isolate obtained from an immunocompromised patient. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Almuzara, M. N., Barberis, C. M., Rodríguez, C. H., Famiglietti, A. M. R., Ramirez, M. S., & Vaya, C. A. (2012). First report of an extensively drug-resistant VIM-2 metallo-β- lactamase-producing Brevundimonas diminuta clinical isolate. Journal of Clinical Microbiology, 50(8), 2830–2832. https://doi.org/10.1128/JCM.00924-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free